Home › United Therapeutics faces patent attack on major drug
 

Keywords :   


United Therapeutics faces patent attack on major drug

2015-06-17 10:51:55| Biotech - Topix.net

United Therapeutics Corporation is facing a possible patent fight over a drug that brings in one-third of the company's total revenue. Watson Laboratories, Inc. submitted an Abbreviated New Drug Application with the U.S. Food and Drug Administration requesting approval to market a generic version of Tyvaso, a drug for which United claims it has patent protection.

Tags: united major drug attack

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »